FDA will take a deeper look into the safety and effectiveness of Lilly experimental Alzheimer’s drug
Eli Lilly expected a decision on donanemab in this year’s first quarter, which ends this month. Read More Source:https://fortune.com/well/2024/03/08/fda-will-take-a-deeper-look-into-the-safety-and-effectiveness-of-lilly-experimental-alzheimers-drug/